BVF Inc
- SEC CIK
- 0001056807
- Latest filing
- Aug 14, 2026
ANTX holding history
AN2 Therapeutics, Inc. in every 13F filed by BVF Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ANTX overviewAll 13F holders of ANTXFull Q2 2026 holdings
- Shares (Q2 2024)
- 0
- Sold out in Q2 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2024 | 0 | $0 | 0.0% | −1,239,470−100.0% | Sold out | Holders |
| Q1 2024 | 1,239,470 | $4.03M | 0.1% | −324,493−20.7% | Reduced | Holders |
| Q4 2023 | 1,563,963 | $32.0M | 0.8% | 00.0% | Unchanged | Holders |
| Q3 2023 | 1,563,963 | $25.1M | 0.7% | 00.0% | Unchanged | Holders |
| Q2 2023 | 1,563,963 | $13.3M | 0.4% | 00.0% | Unchanged | Holders |
| Q1 2023 | 1,563,963 | $15.4M | 0.6% | 00.0% | Unchanged | Holders |
| Q4 2022 | 1,563,963 | $14.9M | 0.6% | −52,702−3.3% | Reduced | Holders |
| Q3 2022 | 1,616,665 | $28.1M | 1.2% | 00.0% | Unchanged | Holders |
| Q2 2022 | 1,616,665 | $12.5M | 0.6% | 00.0% | Unchanged | Holders |
| Q1 2022 | 1,616,665 | $24.4M | 1.0% | +1,616,665 | New | Holders |